Introduction {#joa12572-sec-0001}
============

The pituitary gland is an important endocrine organ composed of two anatomically different entities: the neurohypophysis and the adenohypophysis. While the neurohypophysis originates from the neuroectoderm, the adenohypophysis (anterior pituitary), which is composed of the anterior lobe, intermediate lobe and pars tuberalis, originates from the adenohypophyseal placode (Kouki et al. [2001](#joa12572-bib-0014){ref-type="ref"}). The adenohypophyseal placode is one of the cranial placodes and originates in a common preplacode region. Placode development begins at the border between the neural and non‐neural ectoderm during early gastrulation. After the neural border region is established, it is induced to subdivide into two populations during gastrulation: the preplacode region and the neural crest (NC; reviewed in Singh & Groves, [2016](#joa12572-bib-0019){ref-type="ref"}). Further individualization of the placode domain is established by a reciprocal interaction between placode precursors and NC cells (NCCs).

Placode cells are unipotent and migrate to a region restricted to the head in mammals. In contrast, NCCs exhibit multipotency and are able to differentiate into many types of cells after migrating to the entire body axis. This multipotency of NCCs is sustained in various adult tissues. In the olfactory system, the olfactory epithelium and olfactory ensheathing cells have long been believed to derive solely from the olfactory placode, which is located adjacent to the adenohypophyseal placode during placode development. Recent cell lineage tracing studies by our and other groups using *Wnt1‐Cre/EGFP (enhanced green fluorescent protein)* and/or *P0‐Cre/EGFP* transgenic mice, in which migrating NCCs and their descendants permanently express GFP, revealed that GFP‐positive NCCs play a role not only in embryonic but also in postnatal olfactory development and maintenance (Katoh et al. [2011](#joa12572-bib-0012){ref-type="ref"}; Suzuki et al. [2013](#joa12572-bib-0020){ref-type="ref"}).

In the developing anterior lobe of the anterior pituitary, the presence of NCCs as interstitial cells has been analyzed using quail‐chick chimeras (Couly & Le Douarin, [1987](#joa12572-bib-0002){ref-type="ref"}). Most recently, ablation of NCCs using *Wnt1‐Cre* and *P0‐Cre* to delete *Ctnnb1* (β‐catenin) revealed that NCCs play a role in pituitary vascularization, supplying pericytes (Davis et al. [2016](#joa12572-bib-0004){ref-type="ref"}). The contribution of NCCs to the brain vasculature has previously been reported in mice by our and other groups using *P0‐Cre* and human tissue plasminogen activator *(HtPA)‐Cre* reporter lines (Pietri et al. [2003](#joa12572-bib-0017){ref-type="ref"}; Yamanishi et al. [2012](#joa12572-bib-0022){ref-type="ref"}). However, aside from their role in vasculogenesis, the involvement of NCCs in pituitary development remains unclear. In this study, we further analyzed the contribution of NCCs to pituitary development during the early embryonic period using *P0‐Cre/EGFP* transgenic mice (Kawakami et al. [2011](#joa12572-bib-0013){ref-type="ref"}), in which *P0*‐promoter active NCCs and their descendant NC‐derived cells (NCDCs) are labeled with GFP. Our results demonstrate that NCCs play a pivotal role in pituitary development by differentiating into all types of hormone‐producing cell lineages in addition to pericytes.

Materials and methods {#joa12572-sec-0002}
=====================

Animals {#joa12572-sec-0003}
-------

We used *P0‐Cre/EGFP* transgenic mice generated by crossing *P0‐Cre* mice and *CAG‐CAT‐EGFP* mice (Kawakami et al. [2011](#joa12572-bib-0013){ref-type="ref"}). The original *P0‐Cre* and *CAG‐CAT‐EGFP* transgenic mouse lines were kindly provided by K. Yamamura (Kumamoto University School of Medicine, Kumamoto, Japan) and J. Miyazaki (Osaka University School of Medicine, Osaka, Japan). Mice were housed individually in a temperature‐controlled room under a 12‐h light/12‐h dark cycle. Embryonic stages were determined by observation of vaginal plug day, which was designated as embryonic day 0.5 (E0.5). The present study was approved by the Institute Animal Care and Use Committee, Meiji University, based on NIH Guidelines for the Care and Use of Laboratory Animals.

Immunohistochemistry {#joa12572-sec-0004}
--------------------

Immunohistochemistry was performed as described previously (Yoshida et al. [2009](#joa12572-bib-0024){ref-type="ref"}, [2015](#joa12572-bib-0026){ref-type="ref"}). The following primary antibodies were used: chicken IgY against jelly fish GFP (1 : 500 dilution; Aves Labs, Tigard, OR, USA); rabbit IgG against Cre recombinase (1 : 150 dilution; CST, Danvers, MA, USA); goat IgG against human SOX2 (1 : 400 dilution; Neuromics, Edina, MN, USA); guinea pig IgG against rat PROP1 \[5 ng μL^−1^; generated in‐house (Yoshida et al. [2009](#joa12572-bib-0024){ref-type="ref"})\]; and rabbit IgG against rat NG2 (1 : 400 dilution; Millipore, Darmstadt, Germany). Antisera against anterior pituitary hormones included guinea pig antisera against human growth hormone (GH; 1 : 1500 dilution), which was kindly provided by Dr S. Tanaka (Shizuoka University, Shizuoka, Japan), and rabbit antisera against rat prolactin (PRL; 1 : 5000 dilution), which was kindly provided by Dr Wakabayashi (Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan). Guinea pig antisera against rat adrenocorticotropic hormone (ACTH; 1 : 10000 dilution), rat thyroid‐stimulating hormone (TSH)β (1 : 50000 dilution), rat luteinizing hormone (LH)β (1 : 3000 dilution) and rat follicle‐stimulating hormone (FSH)β (1 : 3000 dilution) were kindly provided by Dr A. F. Parlow (National Hormone and Pituitary Program, Torrance, CA, USA). A cocktail of antisera against six pituitary hormones was prepared by mixing each antiserum in appropriate ratios, as described above. Secondary antibodies used were Cy3‐, Cy5‐, or fluorescein isothiocyanate (FITC)‐conjugated AffiniPure donkey IgG anti‐chicken IgY or anti‐rabbit, anti‐goat and anti‐guinea pig IgG (1 : 500 dilution; Jackson ImmunoResearch, West Grove, PA, USA). Finally, the sections were enclosed in VECTASHIELD mounting medium containing 4,6‐diamidino‐2‐phenylindole (DAPI; Vector, Burlingame, CA, USA). Immunofluorescence was observed under a BZX‐700 fluorescence microscope (Keyence, Osaka, Japan).

Cell numbers positive for GFP, individual hormones, SOX2 and DAPI were counted for each section (6500--9500 cells per section) prepared from three male mice (P60).

Results {#joa12572-sec-0005}
=======

GFP‐positive cells invade the developing anterior pituitary {#joa12572-sec-0006}
-----------------------------------------------------------

*P0‐Cre/EGFP* mice express the Cre recombinase under the *P0*‐promoter, resulting in permanent labeling of NCCs, NCDCs and a population of postnatal vascular precursor cells by GFP (Kubota et al. [2011](#joa12572-bib-0015){ref-type="ref"}). The localization of Cre allows us to identify whether GFP‐positive cells are *P0*‐promoter active or *P0*‐promoter inactive. We first performed double‐immunostaining for Cre and GFP during pituitary embryonic development, determining that a small number of GFP‐positive cells existed inside the invaginating pituitary primordium as early as E9.5 (Fig. [1](#joa12572-fig-0001){ref-type="fig"}A). Whereas Cre/GFP‐double positive cells were localized in the rostral region of the craniofacial mesenchyme, GFP‐positive cells inside the pituitary primordium were Cre‐negative (Fig. [1](#joa12572-fig-0001){ref-type="fig"}A, boxed area). On E10.5 and E11.5, the number of spindle‐shaped GFP‐positive cells increased in the pituitary primordium of Rathke\'s pouch (Fig. [1](#joa12572-fig-0001){ref-type="fig"}B,C). Cre activity inside Rathke\'s pouch was not detected, whereas some GFP‐positive cells outside Rathke\'s pouch were positive for Cre (Fig. [1](#joa12572-fig-0001){ref-type="fig"}C, boxed area), indicating that GFP‐positive but Cre‐negative cells invade the pituitary gland during the early stage of development. Subsequently, during the middle stage of pituitary development (E14.5), in addition to Cre‐negative/GFP‐positive cells, a large number of Cre/GFP‐double positive cells localized to Atwell\'s recess (Fig. [1](#joa12572-fig-0001){ref-type="fig"}D, arrowheads), which is an intraglandular fossa that receives several blood vessels (Daikoku et al. [1981](#joa12572-bib-0003){ref-type="ref"}), and to the rostral tip, which is a prospective pars tuberalis. This was in addition to Cre/GFP‐double positive cells together with Cre‐negative GFP‐positive cells located in the parenchyma of the expanding anterior lobe. This phenomenon was quite different from that on E10.5 and E11.5. On E16.5, when Atwell\'s recess was almost closed, Cre/GFP‐double positive cells and Cre‐negative/GFP‐positive cells were evenly distributed from the rostral to the caudal region of the parenchyma of the anterior lobe (Fig. [1](#joa12572-fig-0001){ref-type="fig"}E). These results demonstrate that the pituitary gland receives at least two waves of invasion by GFP‐positive cells during embryonic development. Furthermore, the populations involved in the two invading waves were different in quality and quantity, consisting of a small *P0*‐promoter inactive population in the first wave and a large population of *P0*‐promoter active and *P0*‐promoter inactive cells in the second wave.

![Localization of GFP‐ and/or Cre‐positive cells during embryonic pituitary development. Sagittal sections on (A) E9.5, (B) E10.5, (C) E11.5, (D) E14.5 and (E) E16.5 were reacted with anti‐Cre antibody (visualized with Cy3, red) and anti‐GFP antibody (visualized with FITC, green). Images of individual staining with DAPI, Cre or GFP, and merged images (left to right panels, respectively) are shown. Boxed areas in (A) and (C) are enlarged in the upper right of each panel. Dotted lines show the outline of the pituitary gland. Solid lines show the outline of the neuroectoderm. Arrowheads indicate Atwell\'s recess. AL, anterior lobe; IL, intermediate lobe; PL, posterior lobe. Scale bars: 100 μm (enlarged area: 10 μm).](JOA-230-373-g001){#joa12572-fig-0001}

GFP‐positive cells acquire the characteristics of pituitary stem/progenitor cells {#joa12572-sec-0007}
---------------------------------------------------------------------------------

We previously reported that all cells in Rathke\'s pouch, except for the rostral tip, express *Sox2*, a pituitary stem/progenitor cell marker, and *Prop1*, a pituitary‐specific progenitor cell marker, on rat E13.5 (Yoshida et al. [2009](#joa12572-bib-0024){ref-type="ref"}). Therefore, we performed triple‐immunostaining for GFP, PROP1 and SOX2 using sections on mouse E11.5 and E14.5 to evaluate the relationship between GFP‐positive cells and pituitary stem/progenitor cells.

On E11.5, after the pituitary primordium received the first wave of invasion, all seven GFP‐positive cells that were observed inside Rathke\'s pouch were positive for PROP1 and SOX2 (Fig. [2](#joa12572-fig-0002){ref-type="fig"}A). GFP‐positive cells were clearly compartmentalized at the border between Rathke\'s pouch and the surrounding head mesenchyme, as shown by GFP‐single positive cells in the mesenchyme (Fig. [2](#joa12572-fig-0002){ref-type="fig"}B, arrows) and GFP/PROP1/SOX2‐triple positive cells inside Rathke\'s pouch (Fig. [2](#joa12572-fig-0002){ref-type="fig"}B,C, arrowheads). These data indicate that GFP‐positive cells inside the pouch acquire characteristics of pituitary stem/progenitor cells after the first wave of invasion and settle in the pituitary together with placode‐derived stem/progenitor cells. In contrast, on E14.5, when the embryonic pituitary receives the second wave of invasion, GFP‐single positive cells were located not only in Atwell\'s recess but also in the parenchyma of the anterior lobe (Fig. [2](#joa12572-fig-0002){ref-type="fig"}D--F′, arrows) together with GFP/PROP1/SOX2‐triple positive cells (Fig. [2](#joa12572-fig-0002){ref-type="fig"}D--F′, arrowheads).

![Characterization of GFP‐positive cells as pituitary stem/progenitor cells. Sagittal sections on (A) E11.5 and (D) E14.5 were reacted with anti‐GFP antibody (visualized with FITC, green), anti‐PROP1 antibody (visualized with Cy3, red) and anti‐SOX2 antibody (visualized with Cy5, gray). Triple‐merged images of the pituitary glands are shown in the upper panels. Boxed areas in A (B, C) and D (E, F) are magnified in the lower panels (B′--F′) as individual images, triple‐merged image and DAPI‐stained image. Arrowheads indicate GFP/PROP1/SOX2‐triple positive cells, and arrows indicate GFP‐single positive cells. Scale bars: 100 μm (enlarged area: 10 μm).](JOA-230-373-g002){#joa12572-fig-0002}

Taken together, our observations suggest that at least GFP‐positive cells penetrated by the first wave of invasion transform into pituitary stem/progenitor cells.

GFP‐positive cells differentiate into hormone‐producing cells and pericytes {#joa12572-sec-0008}
---------------------------------------------------------------------------

We next focused on the GFP‐single positive cells located in the parenchyma of the developing anterior lobe. Because we assume that cells negative for SOX2 and PROP1 in the embryonic anterior lobe commit and terminally differentiate into hormone‐producing cells or cells implicated in vasculogenesis (Yoshida et al. [2009](#joa12572-bib-0024){ref-type="ref"}; Higuchi et al. [2015](#joa12572-bib-0008){ref-type="ref"}; Kanno et al. [2015](#joa12572-bib-0011){ref-type="ref"}), we first performed double‐immunostaining for pituitary hormones and GFP. As the five types of hormone‐producing cells do not appear simultaneously during pituitary development (Savage et al. [2003](#joa12572-bib-0018){ref-type="ref"}), we analyzed the pituitary gland on E16.5, when some hormone‐producing cell lineages have already appeared. Double‐immunostaining with anti‐GFP antibody and a cocktail of antibodies against six pituitary hormones clearly demonstrated that a small number of GFP/hormone‐double positive cells were present in the parenchyma of the developing anterior lobe (Fig. [3](#joa12572-fig-0003){ref-type="fig"}A, upper panel). The proportion of GFP/hormone‐double positive cells among hormone‐producing cells was approximately 3.3%. Additional immunohistochemistry using antibodies against each pituitary hormone revealed GFP‐immunoreactive signals in GH‐, ACTH‐, TSH‐, and LH‐producing cells (Fig. [3](#joa12572-fig-0003){ref-type="fig"}A, lower panels), though signals for PRL and FSH were not detected at this stage.

![Differentiation of GFP‐positive cells into all pituitary hormone‐producing cell lineages. Immunostaining for GFP and pituitary hormones or SOX2 was performed. Merged images of pituitary glands on (A) E16.5 and (B) P60 using anti‐GFP antibody (visualized with FITC, green) and a cocktail of antibodies against six pituitary hormones (visualized with Cy3, red) are shown in the upper panels. Images of co‐localization with GFP (visualized with FITC, green) and each hormone (visualized with Cy3, red) merged with DAPI (blue) are magnified in the lower panels. (C) Images of the pituitary gland on P60 for anti‐GFP (visualized with FITC, green) and anti‐SOX2 (visualized with Cy3, red) are shown. Boxed area is magnified in individual images (GFP,SOX2, GFP/SOX2) and in the merged image with nuclear staining with DAPI (blue). (D) Proportion of GFP‐positive cells among individual hormones‐ or SOX2‐positive cells are shown. Dotted lines in (A) indicate the boundary regions and in (C) indicate the marginal cell layer (MCL). Arrowheads in (C) indicate SOX2/GFP‐double positive cells. ACTH, adrenocorticotrophic hormone; FSH, follicle‐stimulating hormone; GH, growth hormone; LH, luteinizing hormone; PRL, prolactin; TSH, thyroid‐stimulating hormone. Scale bars: 100 μm \[enlarged area (A and B): 10 μm\].](JOA-230-373-g003){#joa12572-fig-0003}

We next tried to confirm the existence of GFP/hormone‐double positive cells in the adult pituitary gland. In the pituitaries of postnatal day 60 (P60) mice, GFP‐positive cells were located not only in the anterior lobe but also in the intermediate lobe (Fig. [3](#joa12572-fig-0003){ref-type="fig"}B, upper panel). Double‐immunostaining for GFP and six pituitary hormones using the antibody cocktail demonstrated that the proportion of GFP/hormone‐double positive cells among hormone‐producing cells had increased to approximately 10%. Further analysis using antibodies against individual hormones confirmed that GFP‐positive cells differentiate into all hormone‐producing cell lineages (Fig. [3](#joa12572-fig-0003){ref-type="fig"}B, lower panels). The proportion of GFP‐positive cells in each hormone‐producing cell was 8.5% (GH), 13.2% (PRL), 6.0% (ACTH), 7.7% (TSH), 5.7% (LH) and 6.0% (FSH; Fig. [3](#joa12572-fig-0003){ref-type="fig"}D), including some melanocyte‐stimulating hormone‐producing cells in the intermediate lobe (data not shown). In addition, we further detected GFP/SOX2‐double positive pituitary stem/progenitor cells in the adult pituitary gland (Fig. [3](#joa12572-fig-0003){ref-type="fig"}C). These cells were located in the marginal cell layer (MCL), a pituitary stem/progenitor cell niche, and the parenchyma of the anterior lobe (Fig. [3](#joa12572-fig-0003){ref-type="fig"}C, boxed area). The proportion of GFP‐positive cells among SOX2‐positive cells was 5.1% (Fig. [3](#joa12572-fig-0003){ref-type="fig"}D).

Finally, we performed double‐immunostaining for GFP and NG2, a potent pericyte marker used to study the developing mouse telencephalon (Yamanishi et al. [2012](#joa12572-bib-0022){ref-type="ref"}), although no marker is absolutely specific for pericytes. *Ng2*, for example, is expressed not only by pericytes but also by oligodendrocyte precursor cells. However, oligodendrocytes are absent from the embryonic anterior pituitary. Therefore, NG2‐positive cells in the embryonic anterior pituitary should consist purely of pericytes. The results showed that NG2‐positive cells were located in Atwell\'s recess and the parenchyma of the embryonic anterior lobe on E14.5 (Fig. [4](#joa12572-fig-0004){ref-type="fig"}A). A portion of NG2‐positive cells in both regions were positive for GFP (Fig. [4](#joa12572-fig-0004){ref-type="fig"}C′,E′, arrowheads), whereas GFP‐negative/NG2‐positive cells were also located in the pituitary gland (Fig. [4](#joa12572-fig-0004){ref-type="fig"}B′,D′, arrows). Hence, our data demonstrate that GFP‐positive cells in the pituitary gland differentiate into two types of cells, hormone‐producing cells and vascular pericytes.

![Differentiation of GFP‐positive cells into pericytes. Sagittal sections on E14.5 were reacted with anti‐GFP antibody (visualized with FITC, green) and anti‐NG2 antibody (visualized with Cy3, red). The image of the pituitary gland is shown as a merged image with DAPI in the upper panel (A). Boxed areas (B--E) are magnified in the lower panels (B′--E′) as individual images, merged image, DAPI‐stained image and triple‐merged image. Arrowheads indicate GFP/NG2‐double positive cells and arrows indicate GFP‐negative/NG2‐positive cells. Scale bars: 100 μm (enlarged area: 10 μm).](JOA-230-373-g004){#joa12572-fig-0004}

Discussion {#joa12572-sec-0009}
==========

Interactions between the pituitary gland and surrounding mesenchymal cells are indispensable for the development of the pituitary gland (Gleiberman et al. [1999](#joa12572-bib-0006){ref-type="ref"}), but their precise roles in pituitary development remain unclear. In the present study, we demonstrated that NCCs invade the embryonic anterior pituitary, which is believed to derive solely from the adenohypophyseal placode, in a stepwise manner and differentiate into all hormone‐producing cell lineages and vascular pericytes.

A reciprocal interaction between placode precursors and NCCs contributes to placode development and individualization, eventually resulting in segregation into the adenohypophyseal, olfactory, lens, trigeminal, epibranchial and otic placodes. Studies focusing on placode‐derived tissues other than the anterior pituitary offer a clue into the contribution of NCCs or NCDCs to the development of placode‐derived tissues. Lineage analyses using *P0‐Cre* transgenic mice have demonstrated that the *P0* promoter is a potent tool for labeling NCCs at stages later than E9.0 (Yamauchi et al. [1999](#joa12572-bib-0023){ref-type="ref"}; Kanakubo et al. [2006](#joa12572-bib-0010){ref-type="ref"}). Indeed, using *P0‐Cre/EGFP* and/or *Wnt1‐Cre/EGFP* transgenic mice, we and another group have reported that NCCs invade the olfactory system during embryogenesis and play a lifelong role in olfactory development together with stem cells derived from the olfactory placode (Katoh et al. [2011](#joa12572-bib-0012){ref-type="ref"}; Suzuki et al. [2013](#joa12572-bib-0020){ref-type="ref"}). In particular, stem cells derived from the NC significantly contribute to reconstruction of the adult olfactory epithelium after severe injury (Suzuki et al. [2013](#joa12572-bib-0020){ref-type="ref"}).

In the present study, using *P0‐Cre/EGFP* transgenic mice, we revealed that GFP‐positive cells invade the anterior pituitary in at least a two‐step process. The first wave of invasion was detected on E9.5, when adenohypophyseal placode cells arrive at an appropriate position to initiate the formation of the pituitary primordium. In the second wave of invasion, we found that a large number of GFP‐positive cells invade the anterior lobe through Atwell\'s recess on E14.5, when vasculogenesis begins. Immunostaining for Cre showed that GFP‐positive cell populations in the second wave of invasion are composed of both Cre‐positive and Cre‐negative cells, whereas those in the first wave of invasion are Cre‐negative only.

In our previous study using *P0‐Cre/EGFP* mouse embryos in whole embryo culture from E8.5 to E9.5, GFP‐expressing cells are indeed labeled with DiI, demonstrating that GFP‐positive cells in the early developmental stage are migrating NCCs (Kanakubo et al. [2006](#joa12572-bib-0010){ref-type="ref"}). Furthermore, in the dental placode, Wang et al. ([2011](#joa12572-bib-0021){ref-type="ref"}) used *P0‐Cre/EGFP* mice to demonstrate that *Cre*‐positive migrating NCCs on E9.0 are transformed into Cre‐negative NC‐derived tooth germ cells on E12.5 and contribute to neonatal dental enamel formation. Taken together, it is reasonable to assume that GFP‐positive cells from the first invasion on E9.5 in the present study are NCDCs. The transcription factor *Prop1* is known to be expressed only in pituitary stem/progenitor cells, and previous reports revealed that all cells in Rathke\'s pouch except for those in the rostral tip are positive for PROP1 (Yoshida et al. [2009](#joa12572-bib-0024){ref-type="ref"}, [2011](#joa12572-bib-0025){ref-type="ref"}). NCDCs in the first wave of invasion were *P0*‐promoter inactive and expressed *Prop1* and *Sox2* within Rathke\'s pouch on E11.5, whereas surrounding mesenchymal cells were *P0*‐promoter active NCCs. These data suggest the possibility that NCCs convert into *P0*‐promoter inactive NCDCs after invasion and transform into pituitary stem/progenitor cells. Immunostaining for six hormones in E16.5 and P60 pituitaries revealed that a small number of hormone‐producing NCDCs are present in the embryonic pituitary gland and differentiate into all hormone‐producing cell lineages, accounting for 10% of all hormone‐producing cells in the adult anterior pituitary gland. These data suggest that NCCs in the first wave of invasion exhibit multipotency, converting into tissue‐specific stem/progenitor cells after invasion and thereafter coexisting with placode‐derived stem/progenitor cells throughout life.

Although the significance of stem/progenitor cells of dual origin in the pituitary gland is poorly understood, the contribution of NC‐derived olfactory stem cells to the regeneration system (Suzuki et al. [2013](#joa12572-bib-0020){ref-type="ref"}) suggests a similar role of NC‐derived stem/progenitor cells in the pituitary gland. Further analyses of regeneration, such as ablation of the target organs, in addition to analyses of the physiological alteration during gestation, lactation and weaning, are needed to clarify this issue. Moreover, in the pituitary gland, folliculo‐stellate cells are known to appear after birth and some of these functions as stem/progenitor cells. One of the folliculo‐stellate cell markers S100β, is expressed in various NC‐derived tissues. Indeed, we recently analyzed the rat late embryonic pituitary gland using anti‐p75, a marker for NCCs, and detected a small number of S100β/p75‐double positive cells (Horiguchi et al. [2016](#joa12572-bib-0009){ref-type="ref"}). Therefore, further analysis of the relationship between NCCs and folliculo‐stellate cells is necessary.

Our observations are consistent with those of a previous tracing analysis using *Nestin‐Cre/GFP* transgenic mice. Gleiberman et al. ([2008](#joa12572-bib-0007){ref-type="ref"}) demonstrated that some GFP‐positive *Nestin‐Cre* lineage cells first settle in Rathke\'s pouch. These subsequently contribute to the expansion of the neonatal pituitary gland and participate in the development of the postnatal pituitary gland as adult pituitary stem cells. *Nestin* is known to be expressed in NC‐derived stem cells within the dorsal root ganglion (Nagoshi et al. [2009](#joa12572-bib-0016){ref-type="ref"}), in addition to neural stem cells in the central nervous system. Together with our present data, these observations suggest that the adult pituitary stem cells identified by analysis of *Nestin‐Cre/GFP* mice may include a population of cells derived from the NC.

We speculated that GFP‐positive cells involved in the second wave of invasion contribute to vasculogenesis in the developing anterior pituitary because they invade from Atwell\'s recess, an intraglandular fossa known to receive primitive portal vessels (Daikoku et al. [1981](#joa12572-bib-0003){ref-type="ref"}). An analysis using quail‐chick chimeras showed that NCDCs exist as interstitial cells in the pituitary (Couly & Le Douarin, [1985](#joa12572-bib-0001){ref-type="ref"}). Moreover, Davis et al. ([2016](#joa12572-bib-0004){ref-type="ref"}) recently reported that cells labeled with X‐gal localized to Atwell\'s recess in the pituitaries of *Wnt1‐Cre*/*Rosa* ^*stopLacZ*^ mice on E14.5, and that *P0‐Cre/β‐catenin* ^*fx/fx*^ transgenic mice, which lack NCCs owing to a deletion of β‐catenin, exhibit abnormal pituitary vasculogenesis. Our findings that pericyte‐like GFP‐positive cells positive for NG2 are located in Atwell\'s recess and the parenchyma of the expanding anterior lobe on E14.5 support these results. We conclude that at least pericyte‐like GFP‐positive cells are NC‐lineage cells.

In addition, we should point out that *P0‐Cre/EGFP* mice mark not only NCCs and NCDCs but also non‐NCCs such as tissue‐resident vascular precursors that are not labeled by *Wnt1‐Cre* or *Ht‐PA‐Cre* mice (Kubota et al. [2011](#joa12572-bib-0015){ref-type="ref"}). These non‐NCCs are P0‐promoter active even in the postnatal period. These reports and our data suggest that plural populations of GFP‐positive cells including NCDCs and tissue‐resident vascular precursor cells invade through Atwell\'s recess and are involved in pituitary vasculogenesis. Considering the significant impact of NC‐derived pericytes in the formation of the avian brain (Etchevers et al. [1999](#joa12572-bib-0005){ref-type="ref"}), the same mechanism may be involved in the avian pituitary gland in order to construct a highly complex organ with multiple types of cells.

Conclusions {#joa12572-sec-0010}
===========

For the first time, we have observed NC‐derived stem/progenitor cells in addition to pericytes in the anterior pituitary. We previously demonstrated that NC‐derived stem cells play a pivotal role in regeneration of the olfactory epithelium after injury (Suzuki et al. [2013](#joa12572-bib-0020){ref-type="ref"}). A remaining question in pituitary organogenesis is whether the two distinct stem/progenitor cell populations originating from the placode and the NC in the embryonic anterior pituitary are involved in distinct functions.
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